Peripheral Venous Pressure Measurements for Heart Failure

This trial aims to determine if daily checks of peripheral venous pressure (pressure in the veins) can shorten hospital stays and reduce rehospitalization for people with congestive heart failure. Participants will either have their vein pressure measured daily or receive standard care without these measurements. The trial is ideal for those who have had congestive heart failure for at least three months, are currently experiencing worsening symptoms, and are admitted to Aurora St. Luke's Medical Center. Participants must be English-speaking and already have a peripheral IV line inserted.

As an unphased trial, this study offers a unique opportunity to contribute to research that could improve future heart failure care.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research shows that measuring peripheral venous pressure (PVP) is safe for patients. Studies have found that PVP closely matches central venous pressure and can be measured easily without surgery or complex procedures.

No direct evidence indicates harmful effects from PVP measurements. Studies have not reported any significant side effects, suggesting that patients generally tolerate it well.

Researchers are excited about peripheral venous pressure measurements for heart failure because this technique could offer a more immediate way to monitor patient status. Unlike standard care, which relies on less frequent assessments, these measurements provide daily updates to physicians. This frequent data could lead to quicker and more tailored treatment decisions, potentially improving patient outcomes by catching issues earlier.

Research has shown that measuring peripheral venous pressure (PVP) closely relates to central venous pressure (CVP), which is crucial for patients with heart failure. Studies indicate that PVP can enhance bedside assessment of heart problems. This trial will compare two approaches: one group will receive daily PVP measurements provided to physicians, while the other group will receive standard clinical care without daily PVP measurements. This method promises a simpler way to check heart stress without invasive procedures. Early evidence suggests that using PVP measurements may reduce hospital stays and readmission rates, making it a potentially effective tool for managing congestive heart failure.¹²³⁴⁶